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1  | INTRODUC TION





projects.1,2	 The	 group	 has	 developed	 the	 UK	ME/CFS	 Biobank2 
(UKMEB),	 a	 biomedical	 research	 resource	 to	 maximize	 research	
efforts,	 using	 a	 similar	 participatory	 approach.1	 Blood	 samples	
collected	from	people	with	ME/CFS	(PWME)	are	stored	alongside	
those	 from	participants	with	Multiple	Sclerosis	 and	healthy	 con-
trols,	 with	 detailed	 clinical	 and	 socio-	demographic	 data	 on	 each	
participant.
Our	 research	 team	 (CureME)	 uses	 the	 data	 and	 samples	 from	


















tations	 of	 existing	 research	 evidence	 and	 no	 universally	 accepted	
treatment	approach.10
Biomedical	 studies	 in	 immunology,11-13	 virology8,14 and neurol-
ogy15-17	 and	 other	 specialty	 fields18-20	 have	 attempted	 to	 explain	
disease	pathways	 in	ME/CFS,	but	 research	findings	are	not	always	
reproducible.21	 The	 aetiology	 remains	 elusive,	 and	 in	 the	 absence	






Multiple	 sclerosis	 (MS)	 was	 chosen	 as	 a	 comparison	 dis-
ease	 for	 ME/CFS,	 because	 while	 MS	 patients	 also	 experience	
chronic	 fatigue	 and	 disabling	 symptoms,	 the	 aetiology	 of	MS	 is	
comparatively	 well	 understood	with	 definitive	 diagnostic	 tests.	



































2.1 | Patient and public involvement in study design




K E Y W O R D S
chronic	fatigue	syndrome,	focus	groups,	multiple	sclerosis,	myalgic	encephalomyelitis,	patient	
and	public	involvement,	qualitative	research
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2.2 | Participant selection
Participants	were	drawn	from	the	380	people	who	had	contributed	







The	 presentations	 and	 focus	 groups	 in	 London	 were	 held	 at	 the	
London	 School	 of	 Hygiene	 and	 Tropical	 Medicine,	 and	 those	 in	
Norwich	 at	 a	 conference/event	 centre.	 Participants	 travelling	 to	
London	were	offered	reimbursement	for	overnight	accommodation	
in	 recognition	 that	 some	would	be	 too	unwell	 to	 return	home	 the	
same	day.	Both	venues	were	wheelchair	 friendly,	and	quiet	 rooms	
with	sofas	were	provided	for	rest	breaks.
2.4 | Content of research presentation
Prior	to	each	focus	group,	participants	viewed	a	30-	min	presenta-
tion	 (by	LN,	EL	and	CK	in	Norwich;	and	by	LN	and	JC	 in	London),	
which	 included	 the	 rationale	 for	 carrying	out	 the	 studies,	 the	 re-
cruitment	 process,	 and	 the	 preliminary	 study	 findings.	 All	 analy-
ses	compared	the	UKMEB	data	and	samples	from	PWME,	people	



















approach	 followed	 the	 procedures	 for	 Thematic	 Analysis	 recom-
mended	by	Braun	and	Clarke.24









After	 data	 coding	 and	 coding-	scheme	 generation,	 codes	 were	
organized	into	potential	themes	to	describe	the	analysed	data.	In	an	




tles.	 Negative	 case	 analyses	 (seeking	 out	 disconfirming	 examples)	




















on	 the	 study	 results,	 how	do	 you	 think	 diagnosis	 of	ME/CFS	
should	be	made?	(For	the	groups	with	ME/CFS	only).
Focus	group	–	task	2
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(17	ME/CFS,	 11	MS).	 Table	1	 summarizes	 the	 composition	 of	 the	
focus	groups,	and	Table	2	summarizes	participant	characteristics.




3.1 | Theme 1: Seeking coherence: Participants’ 
reactions to initial research findings
All	 participants	 express	 a	 compelling	 need	 to	make	 sense	of	 their	






Participants	 suggested	 that	 ME/CFS	 and	 MS	 are	 complex	 ill-
nesses	and	that	finding	answers	was	also	likely	to	be	complex	(Q2).	
They	emphasized	a	need	 for	 interconnected	 thinking	 in	which	dif-

























about	 illness	mechanisms,	 but	wanted	 to	 know	why	MS	might	 be	






3.2 | Theme 2: Seeking a diagnosis: Participants 
explore issues around diagnosis in their lives











chological	 causes.	 Their	 accounts	 of	 these	 experiences	mirrored	
those	 of	 the	ME/CFS	 participants,	 describing	 a	 sense	 of	 “limbo”	
(Q16),	 with	 loss	 of	 self-	confidence	 and	 feelings	 of	 despair.	 The	
turning	 point	 in	 their	 illness	 trajectory	 appeared	 to	 be	 receiving	
a	definite	diagnosis	of	MS.	One	MS	participant	vividly	described	
his	 sense	of	 relief	at	 feeling	 that	he	was	 “not	going	mad,”	and	 to	
have	a	label	for	his	illness	(Q17).	Others	described	similar	feelings	
of	 restored	coherence,	being	able	 to	deal	with	 the	situation,	and	
being	able	to	communicate	their	 illness	to	others	without	fearing	
judgmental	reactions	(Q18,	Q19).	MS	participants	linked	receiving	
Location Members Group size Moderator Duration
Group	1 London Men	with	ME n	=	6 LN	(male) 1 h 23 min
Group	2 London Women	with	ME n	=	5 EL	(female) 1 h 12 min
Group	3 London Women	and	men	
with	MS
n	=	6 CK	(female) 1 h
Group	4 Norwich Women	and	men	
with	ME




TA B L E  1  Summary	of	focus	groups
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a	diagnosis	not	only	with	a	sense	of	validation	and	restored	social	










3.3 | Theme 3. Seeking acceptance: Participants 
explore issues of stigma and validation





Some	 participants	 described	 experiences	 of	 feeling	 disbelieved,	 




















their	 illness	 impacted	 their	 social	 confidence.	 Unpredictable	 epi-
sodes	of	 incontinence	or	problems	with	being	misjudged	as	drunk	
due	 to	 poor-	balance	 could	 lead	 to	 considerable	 social	 embarrass-
ment	and	distress	(Q29).





3.4 | Theme 4. Seeking a better future: Participants’ 
ideas on future research
Participants’	suggestions	on	research	topics	tended,	perhaps	unsur-
prisingly,	to	be	illness-	specific.



























Mild-	moderate 13 - 















aFukuda	 K,	 Straus	 S,	 Hickie	 I,	 Sharpe	M,	Dobbins	 J,	 Komaroff	 A.	 The	
chronic	 fatigue	 syndrome:	 a	 comprehensive	 approach	 to	 its	 definition	
and	 study.	 International	 Chronic	 Fatigue	 Syndrome	 Study	Group.	 Ann	
Intern	Med.	1994;	953-	9.	
bCarruthers	B,	 Jain	A,	De	Meirleir	K,	 et	al.	Myalgic	encephalomyelitis/
chronic	 fatigue	 syndrome:	 clinical	 working	 case	 definition,	 diagnostic	
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tial	 triggers	 for	ME/CFS	such	as	vaccinations	 (Q30),	viruses	 (Q31),	
diet,	and	chemicals	or	environmental	toxins	(Q32).	They	expressed	
particular	appreciation	of	the	use	of	gene	expression	profiling	as	a	
means	 of	 investigating	 potential	 dysfunction	 across	 physiological	
systems	(Q33).
Participants	 also	 suggested	 comparing	 blood	 samples	 from	








clarity	 about	 the	 cause	 of	 their	 illness,	 although	 the	 search	 for	 a	
cure	felt	elusive	(Q33).	Emotions	elicited	by	taking	part	in	research	













3.5 | Theme 5: Seeking to promote understanding; 




Recommended	 target	 audiences,	 predictably,	 included	 doctors	




ered	 particularly	 important	 (Q39),	 with	 easy-	to-	read	 scientific	 ex-
planations	 illustrated	with	personal	stories	for	a	general	readership	






Strategies	 for	 publicizing	 results	 included	 mainstream	 media,	
such	as	newspapers,	radio	and	TV.	Patient	organisations	were	also	




For	 participants	 with	MS,	 an	 overarching	 priority	 for	 dissemi-
nation	appeared	to	be	updating	doctors,	people	with	MS,	and	their	
families	and	friends	on	research	progress	without	raising	unrealistic	





















4.1 | Summary of key results
In	recent	years,	patient	perspectives	have	become	increasingly	im-
portant	 in	 informing	the	 is	planning,	conduct	and	dissemination	of	
research.28	 In	 this	 study,	 participants	 with	ME/CFS	 and	MS	 illus-
trated	 the	 importance	of	 research	as	means	of	 seeking	coherence	
to	make	sense	of	their	 illness	 (Theme	1),	seeking	diagnostic	clarity	
(Theme	 2)	 and	 proof	 of	 illness	 by	 which	 they	 could	 gain	 accept-
ance	and	from	the	medical	profession	and	from	society	(Theme	3).	





mitochondrial	dysfunction	 in	ME,	 triggers	 including	viruses,	 toxins	
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TA B L E  3   (Continued)
(Continues)











text,	 sharing	 research	 results	was	portrayed	not	only	as	providing	
information	to	medical	professionals,	families,	and	others	in	society,	
but	also	as	a	means	of	changing	attitudes.	Participants	called	for	a	
more	 collaborative	 research	 culture,	with	greater	 emphasis	on	ex-
plaining	where	new	knowledge	fitted	into	a	wider	“jigsaw”	of	knowl-
edge,	and	less	on	apparent	“breakthrough”	discoveries.	Participants	






biomedical	 research	means	 to	 them,	 on	 future	 research	 priorities,	
and	approaches	to	sharing	and	publicizing	results.
A	 strength	 of	 using	 focus	 groups	 rather	 than	 individual	 inter-
views	was	the	extent	to	which	participants	were	able	to	interact	in	
their	 reflections,	 often	 eliciting	 richer	 and	more	 complex	 explora-
tion	of	 ideas	 as	 the	discussions	progressed29	However,	 our	 ability	












In	 this	 study,	 all	 focus	 group	 facilitators	 were	 from	 CureME,	
whose	 remit	 is	 biomedical	 research.	 Analysis	 of	 transcripts	 sug-
gested	that	participants	appeared	to	concur	with	that	approach	for	
ME/CFS	 research.	 This	 is	 perhaps	 unsurprising,	 since	 participants	
were	 recruited	 from	 the	 larger	 sample	of	 those	 taking	part	 in	 the	
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This	 study	 involved	 five	 focus	groups.	While	 there	 is	 little	 for-
mal	guidance	on	optimal	numbers	of	focus	groups,	a	study	by	Guest	
et	al	 found	 that	 80%	 of	 all	 themes	 were	 discoverable	 within	 two	
to	three	focus	groups,	and	90%	were	discoverable	within	 three	to	
six	 focus	groups.32	The	 three	ME/CFS	groups	and	two	MS	groups	
showed	marked	similarities	on	 the	 issues	 they	considered	of	most	
importance,	enhancing	credibility	that	the	findings	are	an	authentic	
portrait	of	 the	study	 topic.	Nevertheless,	we	do	not	consider	 that	

























improve	 the	 relevance	 of	 research	 questions	 and	 patient	 recruit-
ment,	 leading	to	results	which	are	more	meaningful	for	patients,35 
and	increasing	chances	of	funding	and	dissemination.28
A	 growing	 body	 of	 international	 literature	 documents	 patient	
participation	 in	 identifying	 research	priorities	 in	many	diseases	 in-
cluding	HIV/AIDS,36	neurological	disabilities,	rheumatoid	arthritis37 
eczema,38kidney	disease,39	Parkinson’s	disease40,41	and	dementia.42






of	 the	 emotional	 and	 experiential	 reasons	 behind	 these	 priorities,	














nosis.	 Exploring	 the	 experiences	of	 two	patient	 groups	have	 shed	
light	on	some	unexpected	parallels,	which	bring	into	sharp	focus	the	
importance	of	how	patients	are	cared	for	when	diagnosis	is	unclear,	
and	 the	 deep	 distress	 caused	when	 patients	 feel	 not	 accepted	 or	
“held”	within	the	patient–doctor	relationship.
Cocksedge	 and	 colleagues	 have	 reflected	 on	 the	 doctor–pa-
tient	relationship	 in	complex	chronic	 illness,	highlighting	the	role	
of	GPs	in	“holding”	patients	at	times	of	uncertainty	and	fear,	even	
when	diagnosis	 is	 unclear	 and	uncertain	 and/or	 there	 is	 no	 cure	
for	the	 illness.48	Chew-	Graham	and	others	have	explored	the	di-
lemmas	 faced	 by	GPs	 in	making	 diagnosis	without	 confirmatory	
tests,49,50	 and	 the	 challenges	 to	 a	 GP’s	 role	 within	 a	 healthcare	





into	 supportive	 acceptance	 with	 a	 confirmed	 diagnosis	 of	 MS.	
Participants	 with	ME/CFS	 longed	 for	 a	 research	 breakthrough	 to	
achieve	a	similar	transformation.	These	mirrored	narratives	raise	the	




4.5 | Recommendations for future research
A	key	study	objective	was	to	find	out	what	patients	viewed	as	im-
portant	 in	 choosing	 directions	 for	 future	 research.	 The	 findings	
signpost	a	diversity	of	specific	topics,	including	investigating	sub-
groups	within	ME,	 immunological	 and	mitochondrial	 dysfunction	
the	 role	 of	 chemical	 and	 environmental	 triggers	 in	ME/CFS,	 and	
genetic,	 viral	 and	 immunological	 factors	 for	MS.	 These	 research	
topics	are	congruent	with	the	intentions	of	CureME	and	UKMEB,	
though	 the	 study	 adds	 specific	 suggestions	which	 the	 team	will	
endeavour	 to	 find	 ways	 of	 including	 within	 future	 research	
collaborations.
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Participants	called	for	researchers	to	be	 less	concerned	about	
claiming	 a	 “breakthrough”	 in	medical	 science	 for	 their	 own	work,	
and	to	put	greater	emphasis	on	contributing	to	a	collaborative	 in-
tegration	 of	 research	 knowledge	 which	 might	 one	 day	 lead	 to	 a	
biomedical	 test,	 effective	 treatments	 or	 cure.	 CureME	 hopes	 to	
fulfil	that	request,	not	only	in	future	dissemination,	but	in	all	inter-
actions	with	the	wider	research	community.	Ours	and	other	similar	




























tive/quantitative	 research;,	 CK—Research	Nurse,	MSc,	 female,	 ex-
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